Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_assertion type Assertion NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_head.
- NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_assertion description "[The use of FASN inhibitors has been limited until now by anorexia and weight loss, which is associated with the stimulation of fatty acid oxidation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_provenance.
- NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_assertion evidence source_evidence_literature NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_provenance.
- NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_assertion SIO_000772 19189648 NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_provenance.
- NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_assertion wasDerivedFrom befree-2016 NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_provenance.
- NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_assertion wasGeneratedBy ECO_0000203 NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_provenance.